Clinical Trials Using Androgen Receptor Antagonist TAS3681
Clinical trials are research studies that involve people. The clinical trials on this list are studying Androgen Receptor Antagonist TAS3681. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Study of TAS3681 in Metastatic Castration Resistant Prostate Cancer
The purpose of this trial is to investigate the safety and tolerability of TAS3681 and to find the maximum tolerated dose of TAS3681.
Location: 4 locations